Biogen Stock is up over 5% as investors wait for news on the FDA decision on Biogen’s Alzheimer drug which may prove to be a game changer for the disease. Analysts have the stock soaring to $450 or higher if approved. Other analysts say the stock will plunge below $200 if not approved.
I entered two trades today in Biogen Stock (BIIB).
The rest of this trade alert and ideas article is for FullyInformed Members.
Biogen Stock (BIIB) – 6th Trade Alert and Idea for Fri Jun 4 2021
Members can sign in to the full members site here
Become a member. Join here, read comments, review benefits
Disclaimer: There are risks involved in all investment strategies and investors can and do lose capital. Trade at your own risk. Stocks, options and investing are risky and can result in considerable losses. None of the strategies, stocks or information discussed and presented are financial or trading advice or recommendations. Everything presented and discussed are the author’s own trade ideas and opinions which the author may or may not enter into. The author assumes no liability for topics, ideas, errors, omissions, content and external links and trades done or not done. The author may or may not enter the trades mentioned. Some positions in mentioned stocks may already be held or are being adjusted.
Internal Stock and Option Trades Links
Put Selling Strategies For Members
Covered Calls Strategies For Members
Profit And Income Strategies Index
Stock and Option Strategies For Members
Stock And Option Trades Explained For Members
